Our Vision
What We Do
Management
Board
Pro-Cure Therapeutics granted fundamental patent on prostate cancer stem cells (Press Release 31 March 2011)
Pro-Cure Therapeutics Limited Secures Further Funding and Strengthens its Board (Press Release 13 April 2010)
Pro-Cure Therapeutics appoints Alastair Riddell as Chairman. (Press Release 1 October 2009)
Pro-Cure Founder and CSO receives prestigious award for work in cancer research. (Press Release 23 June 2009)
UK Biotech companies join forces to develop novel prostate cancer vaccine. (Press Release 14 May 2009)
Cancer Research Company's £2 Million Boost. (Press Release 27 January 2009)
Mapping of prostate cancer genes opens the door to new treatments. (Press Release 20 May 2008)
University of York spin-out secures £550,000 investment in hunt for cancer treatments. (Press Release 8 November 2007)
